Labyrinthin, The Tumor Marker Recognized By MCA 44-3A6: A Case For Pan-Tumor Markers As Targets To Treat Cancer

por Radosevich, James A, Babich, Michael
Publicado 2019

Topology and adenocarcinoma cell localization dataset on the labyrinthin diapeutic biomarker

por Sharma, Ankit, Babich, Michael, Li, Tianhong, Radosevich, James A.
Publicado 2023

Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen

por Babich, Michael, Sharma, Ankit, Li, Tianhong, Radosevich, James A.
Publicado 2022

Nitrosative stress induces DNA strand breaks but not caspase mediated apoptosis in a lung cancer cell line

por Bentz, Brandon G, Hammer, Neal D, Radosevich, James A, Haines, G Kenneth
Publicado 2004

Nitric Oxide: Perspectives and Emerging Studies of a Well Known Cytotoxin

por Paradise, William A., Vesper, Benjamin J., Goel, Ajay, Waltonen, Joshua D., Altman, Kenneth W., Haines, G. Kenneth, Radosevich, James A.
Publicado 2010

Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer

por Ma, Weijie, Zeng, Jie, Montoya, Dennis J., Toomey, Kyra, Zhou, Chihong, Chen, Shuai, Liu, Dingning, Babich, Michael, Radosevich, James A., Li, Tianhong
Publicado 2023

Synthesis and Biological Analysis of Thiotetra(ethylene glycol) monomethyl Ether-Functionalized Porphyrazines: Cellular Uptake and Toxicity Studies

por Lee, Sangwan, Vesper, Benjamin J., Zong, Hong, Hammer, Neal D., Elseth, Kim M., Barrett, Anthony G. M., Hoffman, Brian M., Radosevich, James A.
Publicado 2008